Noninferiority established through high treatment success, low adverse event rates
Findings presented at ESC Congress 2023 and simultaneously published in The New England Journal of Medicine
Read more at prnewswire.comADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints
Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
